Table 1.
Overview of the investigated key attributes of interest for 3D-printed oral dosage forms. Unknown or unpublished data are indicated by “-“.
Printing Technique | Dosage Form | Active Pharmaceutical Ingredient | Assessment of Dose Accuracy | Method of Dose Flexibility | Target Release Profile | Patient Acceptability | Dose Administration | Ref. |
---|---|---|---|---|---|---|---|---|
Extrusion-based; non-heated | Tablet | Spironolactone | Content uniformity | Volume | Similar to commercial tablet: immediate release | Accepted by inpatients, family members, doctors, nurses and pharmacists | Dissolved in water prior to administration | [30] |
Hydrochlorothiazide | ||||||||
Orodispersible tablet | Levetiracetam | Content uniformity | Number of layers | Immediate release | Tablet size not suitable for younger children | Orodispersible | [31] | |
Orodispersible film | Levocetirizine | Content uniformity | Volume | Immediate release | - | Orodispersible | [32] | |
Orodispersible film | Warfarin | Content uniformity | Volume | Immediate release | Acceptable size for children | Orodispersible | [33] | |
Administration through feeding tube | ||||||||
Chewable dosage form | Paracetamol | Drug content assay | Filament length | Extended release | Acceptable palatability | Chewable | [34] | |
Ibuprofen | ||||||||
Orodispersible tablet | Hydrochlorothiazide | Drug content assay | - | Immediate release | - | Orodispersible | [35] | |
Orodispersible film | Warfarin | Drug content assay | Volume | Immediate release | - | Orodispersible | [36] | |
Chewable dosage form | Lamotrigine | - | - | Immediate release | Various colors and shapes | Chewable | [37] | |
Acceptable palatability | ||||||||
Tablet | Jiuxiang Jianpi Yangwei (JJY) | - | - | - | Cartoon shapes | - | [38] | |
Acceptable palatability | ||||||||
Extrusion-based; heated | Tablet | Furosemide | Content uniformity | Drug concentration | Immediate release | Size suitable for children | Swallowable | [39] |
Sildenafil | ||||||||
Chewable tablet | Isoleucine | Drug content assay | Volume | Immediate release | Acceptable palatability; | Chewable | [40] | |
Color and flavor patients choice | ||||||||
Chewable dosage form | Paracetamol | Drug content assay | - | Paracetamol: immediate release | Cartoon shapes | Chewable | [41] | |
Acceptable palatability | ||||||||
Ibuprofen | Ibuprofen: pH dependent | |||||||
Pleasant texture | ||||||||
Tablet | Caffeine | Drug content assay | - | Modified release | Taste masking | - | [42] | |
Dependent on infill percentage | ||||||||
Tablet | Rufinamide | Drug content assay | Multiple tablets | Enhanced drug release | - | - | [43] | |
Chewable dosage form | Ranitidine | Drug content assay | - | Immediate and modified release | Candy shapes | Chewable | [44] | |
Dependent on formulation | Acceptable palatability | |||||||
Orodispersible film | Diclofenac | Drug content assay | Surface area | Immediate release | Taste masking | Orodispersible | [45] | |
Tablet | Caffeine | Mass variation | Volume | Dependent on tablet dimensions | Size suitable for children | Swallowable | [46] | |
Propranolol | ||||||||
Tablet | Lumefantrine | Drug content assay | - | Immediate release | Size suitable for children >6 years | Swallowable | [47] | |
Oral dosage form | Amiodarone | - | Filament length | - | - | - | [48] | |
Tablet | Praziquantel | Drug content assay | Drug concentration | Enhanced drug release | Taste masking | - | [49] | |
Tablet | Baclofen | - | Volume | Modified release | Size suitable for children | Swallowable | [50] | |
Chewable tablet | Indomethacin | - | - | Immediate release | Candy shapes | Chewable | [51] | |
Taste masking | ||||||||
Drop-on-powder | Tablet | Theophylline | Content uniformity | Volume | Similar to commercial tablet: sustained release (theophylline); immediate release (metoprolol tartrate) | - | - | [52] |
Drug concentration | ||||||||
Metoprolol tartrate | Number of ink spraying times | |||||||
Orodispersible tablet | Levetiracetam | - | Volume | Similar to commercial tablet: immediate release | Colorful cartoon shapes | Orodispersible | [53] | |
Inkjet | Orodispersible film | Warfarin | Content uniformity | Surface area | Immediate release | Acceptable size for children | Orodispersible | [33] |
Administration through feeding tube | ||||||||
Orodispersible film | Metoprolol tartrate | Content uniformity | Printing resolution | - | - | Orodispersible | [54] | |
Orodispersible film | Salbutamol | Drug content assay | Drug concentration | - | Size suitable for children | Orodispersible | [55] | |
Orodispersible film | Clonidine | Drug content assay | Drug concentration | Similar to solvent casting: immediate release | - | Orodispersible | [56] | |
Orodispersible film | Enalapril | Drug content assay | - | - | - | Orodispersible | [57] | |
Orodispersible film | Vitamin B1, B2, B3, B6 | Drug content assay | Number of ink spraying times | - | - | Orodispersible | [58] | |
Orodispersible film | Propranolol | Drug content assay | Number of ink spraying times | Immediate release | Acceptable palatability | Orodispersible | [59] |